Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenues, net $ 7,192,694 $ 15,691,430
Cost of goods sold 6,847,511 9,310,256
Gross profit 345,183 6,381,174
Operating expenses:    
General and administration 17,141,882 21,556,976
Sales and marketing 5,336,204 5,908,263
Research and development 12,476,401 17,145,235
Long-term equity investment impairment 1,500,000
Total operating expenses 34,954,487 46,110,474
Operating loss (34,609,304) (39,729,300)
Other income (expense), net    
Other income (expense), net (19,890) (180,904)
Change in fair value of government grant liability 94,962 (478,721)
Interest income 234,930 123,874
Interest expense (3,620,258) (4,154,759)
Foreign exchange loss, net (88,197) (425,062)
Total other income (expense), net (3,398,453) (5,115,572)
Loss before income taxes (38,007,757) (44,844,872)
Provision for income taxes
Net loss (38,007,757) (44,844,872)
Less preferred dividends attributable to noncontrolling interest 1,504,138 512,207
Less deemed dividends attributable to accretion of redemption value 2,907,567 1,001,538
Net loss attributable to common stockholders $ (42,419,462) $ (46,358,617)
Net loss per share - Basic (in Dollars per share) $ (0.61) $ (0.88)
Net loss per share - Diluted (in Dollars per share) $ (0.61) $ (0.88)
Weighted average number of common shares outstanding, basic (in Shares) 69,917,062 52,740,215
Weighted average number of common shares outstanding, Diluted (in Shares) 69,917,062 52,740,215